Gene Query: H1F0

Dataset Description Geneva Score
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 269.33
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 235.25
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 149.35
Region-specific Innate Antiviral Responses of the Human Epididymis 107.07
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 101.93
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 101.9
Genome-wide analysis of the Integrator complex 91.54
Genome-wide analysis of the Integrator complex (HTS) 91.54
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 90.55
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 83.45
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 83.45
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 74.44
Genome wide expression change by RNF168 knocking down in NEC cells 73.69
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 72.6
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 70.15
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 69.29
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 65.85
Characterization of parental and rociletinib-resistant derived H1975 cell lines 65.4
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 64.66
RNA-seq of human aneuploid cell lines with Trisomy 21 62.8
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 62.32
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 58.06
SRSF2 mutations impair hematopoiesis and alter exon recognition 56.89
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 56.83
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 56.46
Gene Expression Profiling of SPOP Knocked Down Cell 55.41
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 54.97
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 54.97
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 54.83
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 52.73
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 52.67
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 52.67
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 51.23
Transcriptional effect of ETV1 knockdown in melanoma cells 51.2
Biological effect of chronic mistranslation in mammalian cells 50.74
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 50.08
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 49.27
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 49.1
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 49.01
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 48.72
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 47.0
Differentially expressed genes post knock down of lincDUSP26 46.23
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 46.03
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 46.03
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 45.48
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 44.9
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 44.9
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 44.89
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 44.89
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 44.77
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 44.44
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 44.44
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 44.06
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 43.8
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 43.76
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 43.75
Gene expression analysis of dengue-infected cells 43.65
TFAP2C signalling in human fibroblasts 43.14
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 42.81
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 42.81
Macrophage Ad5f35 M2 Challenge 41.4
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 41.04
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 40.71
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 40.33
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 40.16
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 40.16
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 39.75
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 39.7
CD86 regulates a pro-survival signal in myeloma cells 39.08
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 39.01
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 38.72
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 38.72
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 38.3
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 38.19
Primary human trophoblast from term placenta 38.09
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 38.08
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 37.48
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 37.39
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 37.28
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 37.19
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 37.19
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 36.77
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 36.69
Spliceosomal disruption of the non-canonical BAF complex in cancer 36.61
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 36.49
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 36.33
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 36.33
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 35.85
MYCi975 regulates MYC target genes 35.66
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 35.29
Generation and functional characterization of MDSC-like cells 35.23
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 35.18
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 35.17
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 35.17
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 34.95
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 34.54
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 34.01
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 33.92
RNA-seq analysis of RALD iPSCs after in vitro differentiation 33.86
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 33.58
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 33.58
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 33.46
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 33.28
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 33.01
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 32.94
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 32.73
Impact on erythroid progenitor type on erythroid differntiation 32.63
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 32.63
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 32.25
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 31.86
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 31.8
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 31.8
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 30.74
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 30.65
RNA sequencing analysis of human embryonic stem cells and axial progenitors 30.27
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 30.26
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 30.26
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 30.22
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 30.13
The DPYSL2 gene connects mTOR and schizophrenia 29.95
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 29.78
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 29.75
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 29.51
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 29.51
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 29.39
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 29.02
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 28.96
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 28.75
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 28.68
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 28.55
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 28.48
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 28.48
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 28.42
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 28.4
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 28.4
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 28.4
RNA-Seq from early time points in the kidney differentiation protocol 28.21
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 28.09
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 27.7
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 27.47
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 27.32
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 27.23
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 26.87
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 26.5
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 26.18
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 26.12
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 26.12
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 26.1
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 25.8
Gene expression profile of multiple myeloma cell lines treated with CB-5083 25.7
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 25.52
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 25.35
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 25.07
Effect of FGF13 depletion on the H460 cell line 25.01
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 25.0
Illumina Total RNA-seq in HeLa 24.99
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 24.97
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 24.9
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 24.66
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 24.66
An siRNA screen identifies CHD4 as a target for epigenetic therapy 24.44
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 24.26
Gene expressions of H9s in different culture systems 24.15
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 24.07
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 23.88
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 23.88
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 23.65
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 23.64
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 23.64
Gene expression profile of human iPSC-derived nephron progenitor cells 23.62
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 23.59
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 23.32
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 23.27
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 23.07
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 23.05
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 22.9
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 22.57
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 22.5
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 22.46
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 22.38
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 22.34
HBEC-shp53-PCHD7 22.17
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 22.08
RNA-sequencing of human liver tissue 22.04
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 22.02
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 21.81
MEIS1 regulates hematopoiesis in hPSCs 21.73
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 21.69
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 21.67
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 21.67
N6-methyladenine DNA Modification in Glioblastoma 21.59
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 21.59
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 21.41
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 21.36
Tracking of dCas9-methyltransferase footprints 21.29
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 21.17
MCF10A H-Ras RNA-Seq 21.15
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 20.96
RNA-seq of young and quiescent MRC-5 human fibroblasts 20.81
Genetic-to-epigenetic Therapy for Pancreatic Cancer 20.59
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 20.59
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 20.53
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 20.51
Effect of mitochondria deficiency on senescence-associated gene expression 20.46
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 20.33
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 20.33
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 20.27
Gene induction by the USP6 oncogene in response to interferon 20.15
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 20.11
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 20.07
Crizotinib v. DMSO in SW480 cells 20.06
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 19.94
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 19.91
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 19.87
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 19.87
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 19.85
IDH3a KO RNA-seq 19.84
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 19.7
Endothelial gene expression analysis 19.7
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 19.65
RNAseq of T-ALL upon long non coding rna purturbation 19.45
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 19.39
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 19.38
miR941 overexpression experiment 19.32
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 19.18
DIGIT regulates endoderm differentiation of human embryonic stem cells 19.18
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 19.16
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 19.13
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 19.11
Gene expression changes in human melanoma cell lines compared to primary melanocytes 18.99
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 18.95
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 18.95
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 18.85
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 18.76
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 18.66
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 18.66
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 18.49
Identification of Sin3B regulated genes during quiescence 18.42
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 18.15
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 18.15
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 18.14
Genome-wide chromatin analysis of Ewing sarcoma 18.14
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 18.1
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 18.03
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 18.03
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 17.92
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 17.87
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 17.73
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 17.7
RNA Seq of HMVEC under hypoxia 17.7
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 17.58
IMP3 regulated gene expression in breast cancer cells 17.55
Pharmacologic inhibition of STAT5 in AML 17.53
Silencing SPIB in attached and floating state of H1703 lung cancer cells 17.49
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 17.33
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 17.33
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 17.21
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 17.2
The role of CFTR in islet function 17.19
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 17.18
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 17.15
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 17.13
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 17.09
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 17.08
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 16.99
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 16.93
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 16.93
HNF1 regulates critical functions of the human epididymis epithelium. 16.93
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 16.89
STRIPAK directs PP2A activity to promote oncogenic transformation 16.84
LNCaP treated with iBET 16.78
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 16.76
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 16.7
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 16.7
Transcriptome-wide identification of CELF2 functional targets in T cells 16.6
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 16.52
MeRIP-seq for heat shock in B-cell lymphoma cells 15.94
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 15.91
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 15.8
SRSF1 role in cellular gene expression and splicing 15.72
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 15.72
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 15.28
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 15.27
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 14.8
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 14.73
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 14.69
RNA transcriptome analysis during HSV-1 infection 14.68
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 14.61
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 14.59
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 14.5
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 14.5
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 14.48
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 14.48
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 14.48
Role of FGFR1 in neuronal devlopment 14.46
Comparative Analysis of Cas9 Activators Across Multiple Species 14.45
Studying the selectivity of a small molecule Synucleozid on transcriptome 14.44
The bromodomain protein BRD4 regulates splicing during heat shock 14.2
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 14.06
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 13.92
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 13.84
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 13.84
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 13.81
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 13.81
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 13.78
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 13.55
Effect of drugs on transcriptomic profiles 13.53
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 13.46
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 13.42
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 13.36
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 13.28
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 13.24
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 13.14
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 13.1
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 13.09
RNA-seq of CD33 KO and control HSPCs 13.08
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 13.03
Proteomics identifies a marker signature of MAPKi resistance in melanoma 12.96
RNA sequencing of human mammary epithelial cells 12.67
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 12.64
Expression profiling of MCF-7 cells with treatment of TCDD 12.64
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 12.63
Effects of rFVIIIFc on human macrophages 12.36
Effect of from Human Umbilical Vein Endothelial Cells 12.28
mRNA expression in human DAOY cells 12.27
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 12.16
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 12.11
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 11.82
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 11.82
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 11.7
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 11.48
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 11.34
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 11.31
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 11.23
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 11.23
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 11.19
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 11.19
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 11.16
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 11.16
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 11.05
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 11.0
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 10.91
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 10.88
Leucegene: ALL sequencing 10.64
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 10.34
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 10.23
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.21
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 10.17
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 10.14
RNA-Seq in PWS iPSC-derived neurons 9.96
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.84
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.77
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.77
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 9.72
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 9.71
Changes in human endometrial gland transcriptome over the window of implantation 9.7
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 9.65
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 9.6
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 9.6
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 9.57
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 9.52
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 9.49
Functional astrocytes differentiated from hiPSCs 9.49
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 9.45
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  9.33
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 9.3
Bone marrow derived human B cells [normal proB] 9.07
Enhancer activation during EGF response 9.06
RNA-seq of IL-4 stimulated human keratinocytes 8.97
Epigenomic conservation of transposable element silencing [RNA-seq] 8.79
Epigenomic conservation of transposable element silencing 8.79
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 8.57
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 8.37
Transcriptome-wide response to synthetic chromatin protein PcTF 8.34
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 8.33
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 8.33
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 8.32
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 8.27
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 8.12
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 8.04
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.0
Hypoxic transcriptome of SQ20B human head and neck cancer cells 7.96
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 7.95
ARID1A and ARID1B loss in HCT116 and TOV21G cells 7.94
Selective expression of long non-coding RNAs in a breast cancer cell progression model 7.93
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 7.84
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 7.78
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 7.74
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 7.65
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 7.64
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 7.59
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 7.54
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.54
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.54
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 7.23
NHLRC1 re-expression in cancer cells 7.23
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 7.14
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 7.06
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.99
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 6.92
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 6.82
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 6.77
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 6.77
PNET animal model: new insights (II) 6.71
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.63
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 6.61
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 6.43
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 6.31
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.29
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.29
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.16
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 5.52
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 5.37
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 5.13
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 5.0
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 4.84
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 4.82
Identification of long noncoding RNAs in T-ALL cell lines 4.61
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.61
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 4.6
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 4.58
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 4.58
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.57
JAK dependent survival of ALK- ALCL 4.4
HEK293 TFAM Knockout Expression Study 4.4
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 4.39
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 4.3
Universal alternative splicing of noncoding exons 4.19
Human T-cell lymphoblastic lymphoma samples and control thymuses 3.93
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 3.93
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.89
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.87
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 3.85
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 3.8
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.74
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.69
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 3.67
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 3.59
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 3.59
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.46
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 3.36
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 3.31
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 3.28
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 3.26
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 3.26
Macrophage Ad5f35 PhenoMap 3.25
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 3.24
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.72
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.66
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.64
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.47
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.38
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.36
Analyses of T-ALL (COG study) 2.29
RNA sequencing of T-ALL (COG study) 2.29
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.23
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.23
6mer seed toxicity in tumour suppressive microRNAs 2.21
RNA-seq of cancer cell lines treated with T-025 2.15
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.08
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.06
Transcriptomic analysis of human macrophages in 3D 2.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 2.05
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.94
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.89
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.65
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.48
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.47
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.47
Co-regulation of splicing by Rbfox1 and hnRNP M 1.47
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.47
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 1.32
Human embryonic stem cells in E8 and AKIT culture medium 1.32
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.3
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.29
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.23
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.15
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.11
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.0
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.99
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.98
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.94
MARCKS and lnc-MARCKS act as inflammation regulators 0.88
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.81
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.74
Ribosomal protein RPL26 is the principal target of UFMylation 0.7
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.69
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 0.62
RNA-seq of primary patient AML samples 0.61
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.5
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.47
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.39
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.37
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.29
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.29
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.14
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.09
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.06
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.05
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation